DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study Evaluating the Safety of Enbrel (Etanercept)

Information source: Wyeth
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Arthritis, Psoriatic

Intervention: Etanercept (Enbrel) (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth

Overall contact:
Trial Manager, Email: clintrialparticipation@wyeth.com


The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.

Clinical Details

Official title: A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection

Study design: Case-Only, Prospective

Primary outcome: Spontaneous Adverse Events will be collected until 30 days after each injection


Minimum age: N/A. Maximum age: N/A. Gender(s): Male.


Inclusion Criteria:

- All patients from the study center who received or will receive at least one dose of

Enbrel according to the approved product indication and who have not previously discontinued therapy due to safety concerns.

Exclusion Criteria:

- N/A

Locations and Contacts

Trial Manager, Email: clintrialparticipation@wyeth.com

Mandaluyong City, Philippines; Recruiting

Tucson, Arizona 85741, United States; Recruiting

Ocala, Florida 34474, United States; Recruiting

DeLand, Florida 32720, United States; Recruiting

Atlanta, Georgia 30308, United States; Recruiting

Wallingford, Pennsylvania 19086, United States; Recruiting

Roanoke, Virginia 24018, United States; Recruiting

Additional Information

Starting date: January 2007
Ending date: December 2009
Last updated: September 10, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015